PIDOTIMOD A NEW EFFICIENT PRODUCT IN IMMUNOLOGICAL PROPHYLAXIS AND IMMUNOLOGICAL THERAPY OF RESPIRATORY INFECTIONS IN CHILDREN
The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and other medicat...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2008-01-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1347 |
| Summary: | The article contains analysis of results of international trial of pidotimod (imunorix) efficiency. pidotimod is a new safe immunomodulator, which is both efficient in prophylactic use and as a medication. At the same time, the drug is capable of intensify the effect of antibiotics and other medications. This fact is confirmed by the results of controlled trials with participation of a large number of patients. pidotimod is ministerial to a faster disappearance of signs and symptoms of infection, anticipating the recovery with reduced administration of associated drugs.Key words: pidotimod, immunomodulator, acute respiratory infections, prophylaxis, treatment. |
|---|---|
| ISSN: | 1682-5527 1682-5535 |